M1RN34:BVMF
Moderna Inc Bdr
၅၆.၀၀ R$
၀.၀၀%
(၀.၀၀) 1D
အောက် ၉, GMT-၃ ၁၇:၀၆:၀၀ · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for M1RN34...
Open
၄၉.၇၀ R$
High
၅၆.၀၀ R$
Low
၄၉.၃၀ R$
Mkt. cap
ဋေ ၈.၉၈ ထ
Avg. vol.
၁.၀၆ သိန်း
Volume
၂.၃၇ သိန်း
52-wk high
၅၆.၀၀ R$
52-wk low
၆.၀၂ R$
Shares outstanding
၃၉.၉၂ ကုဋေ
No. of employees
၅ ထောင်
Open
၄၉.၇၀ R$
High
၅၆.၀၀ R$
Low
၄၉.၃၀ R$
Mkt. cap
ဋေ ၈.၉၈ ထ
Avg. vol.
၁.၀၆ သိန်း
Volume
၂.၃၇ သိန်း
52-wk high
၅၆.၀၀ R$
52-wk low
၆.၀၂ R$
Shares outstanding
၃၉.၉၂ ကုဋေ
No. of employees
၅ ထောင်
News stories
From web sources and news partners
JournalArta
·
ပြီးခဲ့သည့် ၁၁ နာရီ
Covid vaccine stock S&P leader surges: What to Know
Simply Wall Street
·
ပြီးခဲ့သည့် ၁၇ နာရီ
Moderna Stock Surge Puts These Oncology Biotechs On Retail Investors Radar
The Motley Fool
·
ပြီးခဲ့သည့် ၁ ရက်
Moderna Now Trades 61% Above Wall Street's Average Price Target. Should You Sell?
The Globe and Mail
·
ပြီးခဲ့သည့် ၂ ရက်
This Stock Is Up More than 560% This Year, but It Could Drop by 38%, According to Wall Street
Profile
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. Wikipedia
About Moderna Inc Bdr